Glucose availability and glycolytic metabolism dictate glycosphingolipid levels

Journal of cellular biochemistry

Volumn 116, Issue 1, 2015, Pages 67-80

  Stathem, Morgan ^a   Marimuthu, Subathra ^b   O'Neal, Julie ^b   Rathmell, Jeffrey C ^b   Chesney, Jason A ^b   Beverly, Levi J ^b   Siskind, Leah J ^b  

^a University of Louisville School of Medicine   (United States)

^b NONE

Author keywords

2 DEOXYGLUCOSE; 2 DG; 6 AMINONICATINOMIDE; 6 AN; ABT 263; ABT 737; APOPTOSIS; CERAMIDE; GCS; GlcCer; GluCer; GLUCOSE; GLUCOSYLCERAMIDE; GLUCOSYLCERAMIDE SYNTHASE; GLYCOLYSIS; GLYCOSPHINGOLIPID; GSL; METABOLISM; PENTOSE PHOSPHATE PATHWAY; PPP; SPHINGOLIPID

Indexed keywords

ANILINE DERIVATIVE; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; GLUCOSE; GLUCOSYLTRANSFERASE; GLYCOSPHINGOLIPID; NAVITOCLAX; SPHINGOLIPID; SULFONAMIDE;

CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GLYCOLYSIS; HUMAN; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANILINE COMPOUNDS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; GLUCOSE; GLUCOSYLTRANSFERASES; GLYCOLYSIS; GLYCOSPHINGOLIPIDS; HUMANS; SPHINGOLIPIDS; SULFONAMIDES;

EID: 85017304230     PISSN: None     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24943     Document Type: Article

References (0)